Julian P T Higgins

Summary

Affiliation: University of Cambridge
Country: UK

Publications

  1. ncbi Meta-analysis of continuous outcome data from individual patients
    J P Higgins
    MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 2SR, U K
    Stat Med 20:2219-41. 2001
  2. ncbi Sequential methods for random-effects meta-analysis
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 0SR, U K
    Stat Med 30:903-21. 2011
  3. ncbi Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 0SR, UK
    Int J Epidemiol 37:1158-60. 2008
  4. ncbi Quantifying heterogeneity in a meta-analysis
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, UK
    Stat Med 21:1539-58. 2002
  5. ncbi Meta-analysis of skewed data: combining results reported on log-transformed or raw scales
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    Stat Med 27:6072-92. 2008
  6. ncbi Imputation methods for missing outcome data in meta-analysis of clinical trials
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, UK
    Clin Trials 5:225-39. 2008
  7. ncbi Measuring inconsistency in meta-analyses
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 2SR
    BMJ 327:557-60. 2003
  8. ncbi Controlling the risk of spurious findings from meta-regression
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, U K
    Stat Med 23:1663-82. 2004
  9. ncbi Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models
    Ian R White
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    Stat Med 27:728-45. 2008
  10. ncbi How should meta-regression analyses be undertaken and interpreted?
    Simon G Thompson
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, UK
    Stat Med 21:1559-73. 2002

Detail Information

Publications44

  1. ncbi Meta-analysis of continuous outcome data from individual patients
    J P Higgins
    MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 2SR, U K
    Stat Med 20:2219-41. 2001
    ..Relative merits of the three software packages for such meta-analyses are discussed, as are the assessment of model assumptions and extensions to incorporate more than two treatments...
  2. ncbi Sequential methods for random-effects meta-analysis
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 0SR, U K
    Stat Med 30:903-21. 2011
    ..We illustrate the method using an example in the treatment of bleeding peptic ulcers...
  3. ncbi Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 0SR, UK
    Int J Epidemiol 37:1158-60. 2008
  4. ncbi Quantifying heterogeneity in a meta-analysis
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, UK
    Stat Med 21:1539-58. 2002
    ..One or both should be presented in published meta-analyses in preference to the test for heterogeneity...
  5. ncbi Meta-analysis of skewed data: combining results reported on log-transformed or raw scales
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    Stat Med 27:6072-92. 2008
    ..An assumption can be made that the standard deviations in the two groups are equal. This increases precision of the estimates, but if incorrect can lead to very misleading results...
  6. ncbi Imputation methods for missing outcome data in meta-analysis of clinical trials
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, UK
    Clin Trials 5:225-39. 2008
    ..An intention-to-treat analysis should take account of all randomized participants even if they have missing observations...
  7. ncbi Measuring inconsistency in meta-analyses
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 2SR
    BMJ 327:557-60. 2003
  8. ncbi Controlling the risk of spurious findings from meta-regression
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, U K
    Stat Med 23:1663-82. 2004
    ..The permutation test appropriately tempers the statistical significance of meta-regression findings. We recommend its use before a statistically significant relationship is claimed from a standard meta-regression analysis...
  9. ncbi Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models
    Ian R White
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    Stat Med 27:728-45. 2008
    ..By applying the method in three different data sets, we show that it is possible to appropriately capture the extra uncertainty due to missing data, and we discuss in what circumstances it is possible to learn about the IMOR...
  10. ncbi How should meta-regression analyses be undertaken and interpreted?
    Simon G Thompson
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, UK
    Stat Med 21:1559-73. 2002
    ..The examples considered in this paper show the tension between the scientific rationale for using meta-regression and the difficult interpretative problems to which such analyses are prone...
  11. ncbi Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods
    Ian R White
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    Stat Med 27:711-27. 2008
    ..We illustrate the methods using a meta-analysis on psychiatric interventions in deliberate self-harm...
  12. ncbi Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?
    Simon G Thompson
    MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 2 sR, UK
    Lancet 365:341-6. 2005
    ..Also, although meta-analyses generally summarise an intervention's effect as a relative risk reduction, the groups of patients with the greatest absolute risk reduction have the most to gain...
  13. ncbi Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene-gene-environment interaction
    Georgia Salanti
    MRC Biostatistics Unit, Cambridge, U K
    Stat Med 25:4147-63. 2006
    ..The methodology is implemented in an original meta-analysis of studies relating the risk of bladder cancer to two N-acetyltransferase genes, NAT1 and NAT2, and smoking status...
  14. ncbi Online genetic databases informing human genome epidemiology
    Angela J Frodsham
    Public Health Genetics Unit, Strangeways Research Laboratory, Cambridge, UK
    BMC Med Res Methodol 7:31. 2007
    ..A first port of call for most such reviews is a search of MEDLINE. We examined whether this could be usefully supplemented by identifying databases on the World Wide Web that contain genetic epidemiological information...
  15. ncbi Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
    Mark C Simmonds
    MRC Biostatistics Unit, Robinson Way, Cambridge, UK
    Clin Trials 2:209-17. 2005
    ..The impact of heterogeneity, or use of random effects, are seldom discussed. There is thus considerable scope for enhancing the methods of analysis and presentation of IPD meta-analysis...
  16. ncbi Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium
    Georgia Salanti
    MRC Biostatistics Unit, Cambridge, UK
    Stat Med 26:553-67. 2007
    ..The proposed hierarchical models allow the synthesis of data across gene-disease association studies with appropriate consideration of HWE issues...
  17. ncbi Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies
    Zheng Ye
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Site, Cambridge, United Kingdom
    PLoS Med 3:e91. 2006
    ..It has been suggested that polymorphisms in the GST genes are risk factors for lung cancer, but a large number of studies have reported apparently conflicting results...
  18. ncbi Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review
    John Danesh
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    PLoS Med 5:e78. 2008
    ..We updated a systematic review to put the new findings in context...
  19. ncbi Challenges in the use of literature-based meta-analysis to examine gene-environment interactions
    Luigi Palla
    Institute of Metabolic Science, Cambridge University Hospital Foundation Trust, United Kingdom
    Am J Epidemiol 171:1225-32. 2010
    ..This issue may ultimately only be resolvable by the de novo establishment of large single or multicenter cohorts using comparable methods...
  20. ncbi Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis
    Adam S Butterworth
    Public Health Genetics Unit, Cambridge Genetics Knowledge Park, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK
    Eur J Cancer 42:216-27. 2006
    ..8 to 4.0) with at least one affected relative or 6.9% (95% CI 4.5 to 10.4) with two or more. Accurate absolute risk estimates show how cancer risks vary over time, particularly by pattern of family history and age of individual at-risk...
  21. ncbi Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography
    Simon Sanderson
    Primary Care Genetics, General Practice and Primary Care Research Unit, University of Cambridge and Public Health Genetics Unit, Strangeways Research Labs, Worts Causeway, Cambridge, UK
    Int J Epidemiol 36:666-76. 2007
    ..Tools for assessing quality in clinical trials are well-described but much less attention has been given to similar tools for observational epidemiological studies...
  22. ncbi The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis
    Hebe N Gouda
    Department of Public Health and Primary Care, University ofCambridge, Cambridge CB2 0SR, UK
    Am J Epidemiol 171:645-55. 2010
    ..Work on PPARG Pro12Ala should now focus on the observed heterogeneity in the magnitude of the association between populations. Further investigations into gene-gene and gene-environment interactions may prove enlightening...
  23. ncbi Obstacles and opportunities in meta-analysis of genetic association studies
    Georgia Salanti
    MRC Biostatistics Unit, Cambridge, UK
    Genet Med 7:13-20. 2005
    ..We believe that systematic review and meta-analysis has an important role to play in understanding genetic association studies and should help us to separate the wheat from the chaff...
  24. ncbi A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered
    Georgia Salanti
    MRC Biostatistics Unit, Cambridge, UK
    J Clin Epidemiol 62:857-64. 2009
    ....
  25. ncbi Estimating within-study covariances in multivariate meta-analysis with multiple outcomes
    Yinghui Wei
    MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 0SR, UK
    Stat Med 32:1191-205. 2013
    ..An application to a meta-analysis of treatments for stroke illustrates the use of the approximated covariance in multivariate meta-analysis with correlated outcomes...
  26. ncbi The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews
    Rebecca M Turner
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, United Kingdom
    PLoS ONE 8:e59202. 2013
    ..We examine the distribution of power available in studies within meta-analyses published in Cochrane reviews, and investigate the impact of underpowered studies on meta-analysis results...
  27. ncbi Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis
    Caroline F Wright
    PHG Foundation, 2 Worts Causeway, Cambridge, UK
    BMC Res Notes 5:476. 2012
    ..We applied a sensitive search of multiple bibliographic databases including PubMed (MEDLINE), EMBASE, the Cochrane library and Web of Science...
  28. ncbi Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis
    Jonathan Davey
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    BMC Med Res Methodol 11:160. 2011
    ..The characteristics of these reviews and the meta-analyses and individual studies they contain provide insights into the nature of healthcare research and important context for the development of relevant statistical and other methods...
  29. ncbi Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction
    Julian P T Higgins
    MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
    Int J Epidemiol 31:96-104. 2002
    ....
  30. ncbi Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects
    Gurdeep S Sagoo
    MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom
    Genet Med 11:139-46. 2009
    ..However, given that this technology also identifies false positives at a similar rate to causal variants, caution in clinical practice should be advised...
  31. ncbi Meta-analyses involving cross-over trials: methodological issues
    Diana R Elbourne
    Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
    Int J Epidemiol 31:140-9. 2002
    ..This paper concentrates on RCTs of a different design-two-period, two-treatment cross-over trials...
  32. ncbi Meta-analysis in occupational epidemiology: a review of practice
    Damien M McElvenny
    Public and Environmental Health Research Unit, London School of Hygiene and Tropical Medicine, London, UK
    Occup Med (Lond) 54:336-44. 2004
    ..To describe past practice in meta-analyses found in occupational epidemiology, identifying the major issues that should be considered by researchers planning a meta-analysis in this setting...
  33. ncbi Meta-analysis of genetic association studies under different inheritance models using data reported as merged genotypes
    Georgia Salanti
    Clinical and Molecular Epidemiology Unit, University of Ioannina School of Medicine, Ioannina, Greece
    Stat Med 27:764-77. 2008
    ....
  34. ncbi Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls
    Zheng Ye
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Site, Wort's Causeway, Cambridge CB1 8RN, UK
    Lancet 367:651-8. 2006
    ....
  35. ncbi Assessment of cumulative evidence on genetic associations: interim guidelines
    John P A Ioannidis
    Clinical and Molecular Epidemiology Unit, University of Ioannina School of Medicine, Ioannina 45110, Greece
    Int J Epidemiol 37:120-32. 2008
    ..Future empirical research and consensus development are needed to develop an integrated model for combining epidemiological and biological evidence in the rapidly evolving field of investigation of genetic factors...
  36. ncbi Turning the pump handle: evolving methods for integrating the evidence on gene-disease association
    Julian P T Higgins
    Am J Epidemiol 166:863-6. 2007
  37. ncbi A road map for efficient and reliable human genome epidemiology
    John P A Ioannidis
    Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, and Biomedical Research Institute, Foundation for Research and Technology Hellas, Ioannina 45110, Greece
    Nat Genet 38:3-5. 2006
    ..Systematic reviews will be expanded to include more meta-analyses of individual-level data and prospective meta-analyses. Field synopses will offer regularly updated overviews...
  38. ncbi The emergence of networks in human genome epidemiology: challenges and opportunities
    Daniela Seminara
    Epidemiology and Genetics Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, EPN Bldg, Rm. 5142, MSC 7393, 6130 Executive Blvd, Bethesda, MD 20892, USA
    Epidemiology 18:1-8. 2007
  39. ncbi Response to paper by Lang A, Edwards N, and Fleiszer A
    Sally Green
    Monash University, Australasian Cochrane Centre, Melbourne, Australia
    J Clin Epidemiol 60:598-9. 2007
  40. ncbi Systematic review of controlled trials on the effectiveness of fluoride gels for the prevention of dental caries in children
    Valeria C C Marinho
    Systematic Reviews Training Unit, Institute of Child Health, London
    J Dent Educ 67:448-58. 2003
    ..2 D(M)FS/year, or an NNT of twenty-four (95 percent CI, 18 to 36) based on an increment of 0.2 D(M)FS/year. However, further work is needed to identify and quantify potential harmful effects of fluoride gels...
  41. ncbi A network of investigator networks in human genome epidemiology
    John P A Ioannidis
    Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
    Am J Epidemiol 162:302-4. 2005
    ....
  42. ncbi Relative efficacy of differential methods of dietary advice: a systematic review
    Rachel L Thompson
    Institute of Human Nutrition, University of Southampton, Southampton, UK
    Am J Clin Nutr 77:1052S-1057S. 2003
    ..Dietary advice to lower blood cholesterol may be given by a variety of means. The relative efficacy of the different methods is unknown...
  43. ncbi Evaluation of networks of randomized trials
    Georgia Salanti
    Clinical and Molecular Epidemiology Unit and Clinical Trials and Evidence Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece
    Stat Methods Med Res 17:279-301. 2008
    ..Finally, we discuss the implications of inconsistency, network geometry and asymmetry in informing the planning of future trials...
  44. ncbi Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
    Lee Hooper
    School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ
    BMJ 332:752-60. 2006
    ..To review systematically the evidence for an effect of long chain and shorter chain omega 3 fatty acids on total mortality, cardiovascular events, and cancer...